AXMI-IL 5, AXMI-113, AXMI-005, AXMI-163 and AXMI-184 : VIP3A insecticidal proteins from Bacillus thuringiensis and methods for their use

Details for Australian Patent Application No. 2009266906 (hide)

Owner Athenix Corporation

Inventors Campbell, Chris; Agarwal, Shruti; Duck, Nicholas B.; Sampson, Kimberly S.; Carozzi, Nadine; Koziel, Michael G.; McNulty, Brian; Tomso, Daniel J.; Heinrichs, Volker; Hargiss, Tracy

Agent Davies Collison Cave

Pub. Number AU-A-2009266906

PCT Pub. Number WO2010/003065

Priority 61/077,812 02.07.08 US; 61/158,953 10.03.09 US

Filing date 2 July 2009

Wipo publication date 7 January 2010

International Classifications

C07K 14/325 (2006.01) Peptides having more than 20 amino acids

C12N 15/82 (2006.01) Mutation or genetic engineering - for plant cells

Event Publications

20 January 2011 PCT application entered the National Phase

  PCT publication WO2010/003065 Priority application(s): WO2010/003065

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009266917-Controlled and localized release of retinoids to improve neointimal hyperplasia

2009266904-Apparatus for attenuating ultrasonic waves propagating within a pipe wall